Categories
Articles

Eli Lilly’s 3-step strategy to dominate the $95 billion obesity market

Business Insider Business Insider

Categories
Articles

Eli Lilly’s Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says

Business Insider Business Insider

Categories
Articles

Novo Nordisk Slashes Insulin Prices, Following Eli Lilly’s Lead

Entrepreneur: Latest Articles

Categories
Articles

Eli Lilly’s Price Cut Is Gamechanging. But Insulin Isn’t the Only High Cost for People With Diabetes

TIME

Categories
Articles

Here’s How the Other Major Insulin Makers Are Responding After Eli Lilly’s Price Cap

TIME